Respiratory diseases, common examples of which include asthma and chronic obstructive pulmonary disease (COPD), affect one in five people in...
care
Introduction Acute kidney injury (AKI), characterized by an abrupt deterioration of kidney function, is common in adults and children, and...
Introduction Burnout is a widespread and significant issue with profound consequences for both individuals and organizations. It is characterized by...
Artificial intelligence (AI) can be used in respiratory care for patient triage, chest x-ray categorization, and patient self-management, but regulatory...
Author: Precedence Research Omlyclo is the first omalizumab biosimilar that Health Canada has approved exclusively for use in Canada. It...
MucoLife Therapeutics, an alumnus of the Health Wildcatters accelerator, develops patented, innovative mucus-dissolving therapies specifically targeting pulmonary mucus obstruction. In...
